» Articles » PMID: 26613051

Sucupira As a Potential Plant for Arthritis Treatment and Other Diseases

Overview
Journal Arthritis
Specialty Rheumatology
Date 2015 Nov 28
PMID 26613051
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Trees of the genus Pterodon, commonly known as "sucupira-branca" or "faveira," are native to central Brazil. The Pterodon fruits are traditionally used in ethnomedicine as an infusion, in small doses, and at regular time intervals as an antirheumatic, anti-inflammatory, tonic, and depurative agent. The various compounds present in the Pterodon class are, generally, water-insoluble and derived from the fusion of high-molecular weight pentacarbonate units. Scientific research has shown that the major compounds isolated from Pterodon species are linear and/or tetracyclic diterpenes with vouacapane skeletons that partly underlie the pharmacological activities of the fruit-derived oil. Material from Pterodon species has several biological properties, such as analgesic, anti-inflammatory, and anticancer effects. Therefore, recent studies have sought to microencapsulate these extracts to protect them from potential chemical degradation and improve their water solubility, ensuring greater stability and quality of the end products. This review presents a succinct overview of the available scientific evidence of the biological activity and toxicity of Pterodon species in addition to other important aspects, including phytochemical and technological features.

Citing Articles

The Potential of Vouacapanes from Vogel Against COVID-19 Cytokine Storm.

Oliveira L, da Silva A, Thomaz D, Brandao F, da Conceicao E, Valadares M Adv Pharm Bull. 2023; 13(1):150-159.

PMID: 36721819 PMC: 9871284. DOI: 10.34172/apb.2023.016.


Lecithin-based nanocapsule loading sucupira () oil effects in experimental mucositis.

Di Miceli J, Andrade M, Carvalho P, Santos E, de Faria Mota Oliveira A, Fernandes C Toxicol Rep. 2022; 9:1537-1547.

PMID: 36518414 PMC: 9743464. DOI: 10.1016/j.toxrep.2022.07.006.


Recent progress in micro and nano-encapsulation of bioactive derivatives of the Brazilian genus Pterodon.

de Alcantara Lemos J, Oliveira A, Araujo R, Townsend D, Ferreira L, de Barros A Biomed Pharmacother. 2021; 143:112137.

PMID: 34507118 PMC: 8963538. DOI: 10.1016/j.biopha.2021.112137.


Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.

Vieira R, Severino P, Nalone L, Souto S, Silva A, Lucarini M Molecules. 2020; 25(3).

PMID: 32041134 PMC: 7038118. DOI: 10.3390/molecules25030685.


Essential oil of Pterodon polygalaeflorus Benth attenuates nociception in mice.

Coelho-de-Souza A, Dos-Santos C, Lopes-Filho L, Holanda F, Oliveira A, Gomes-Vasconcelos Y Braz J Med Biol Res. 2018; 51(11):e7356.

PMID: 30304130 PMC: 6172927. DOI: 10.1590/1414-431X20187356.


References
1.
Katz N, dos SANTOS FILHO D, Sarti S, Mendes N, Rocha Filho P, Araujo N . [Chemoprophylactic activity on Schistosomiasis mansoni of soaps containing essential oil from the fruits of Pterodon pubescens]. Rev Inst Med Trop Sao Paulo. 1993; 35(2):183-91. View

2.
Duarte I, Ferreira-Alves D, Veloso D . Evidence of the involvement of biogenic amines in the antinociceptive effect of a vouacapan extracted from Pterodon polygalaeflorus Benth. J Ethnopharmacol. 1996; 55(1):13-8. DOI: 10.1016/s0378-8741(96)01465-1. View

3.
Menna-Barreto R, Laranja G, Silva M, Coelho M, Paes M, Oliveira M . Anti-Trypanosoma cruzi activity of Pterodon pubescens seed oil: geranylgeraniol as the major bioactive component. Parasitol Res. 2008; 103(1):111-7. DOI: 10.1007/s00436-008-0937-0. View

4.
Coelho M, Marques P, Gayer C, Vaz L, Neto J, Sabino K . Subacute toxicity evaluation of a hydroalcoholic extract of Pterodon pubescens seeds in mice with collagen-induced arthritis. J Ethnopharmacol. 2001; 77(2-3):159-64. DOI: 10.1016/s0378-8741(01)00288-4. View

5.
Coelho M, Sabino K, Dalmau S . Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis. Clin Exp Rheumatol. 2004; 22(2):213-8. View